|
|
Article: VaxGen Responds to Media Report Regarding Proposed Congressional Investigation of Anthrax Vaccine Contract.
- Article from:
- PR Newswire
- Article date:
- April 6, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BRISBANE, Calif., April 5 /PRNewswire-FirstCall/ -- VaxGen, Inc. (Pink Sheets: VXGN.PK) issued the following statement today from its President and Chief Executive, Lance K. Gordon, Ph.D., in response to a proposed investigation into the company's anthrax vaccine contract by Congressman Mike Rogers (R-Mich.), which was reported in an Associated Press article.
(Logo: http://www.newscom.com/cgi-bin/prnh/19991112/VAXGENLOGO )
"We were surprised by Congressman Rogers' call for an investigation of our Project BioShield anthrax vaccine contract, because:
-- The Department of Health and Human Service's (HHS) award in November
2004 of a ...